KFS
Kurt F. Somerville Portfolio holdings
AUM
$594M
This Quarter Return
+3.17%
1 Year Return
+12.39%
3 Year Return
+68.79%
5 Year Return
+108.17%
10 Year Return
+271.21%
AUM
$438M
AUM Growth
+$438M
(+0.05%)
Cap. Flow
-$10.1M
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
38.36%
Holding
126
New
2
Increased
24
Reduced
58
Closed
14
Top Buys
| 1 |
Chubb
CB
|
$3M |
| 2 |
Gilead Sciences
GILD
|
$1.59M |
| 3 |
Danaher
DHR
|
$1.18M |
| 4 |
Unilever
UL
|
$986K |
| 5 |
Perrigo
PRGO
|
$795K |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$2.59M |
| 2 |
EMC
EMC CORPORATION
EMC
|
$2.52M |
| 3 |
Emerson Electric
EMR
|
$2.18M |
| 4 |
CB
CHUBB CORPORATION
CB
|
$1.3M |
| 5 |
CVS Health
CVS
|
$788K |
Sector Composition
| 1 | Healthcare | 23.6% |
| 2 | Technology | 22.18% |
| 3 | Industrials | 16.38% |
| 4 | Consumer Staples | 10.57% |
| 5 | Financials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Emerson Electric
EMR
$73.3B
| $6.16M | 1.41% |
113,278
-40,046
| -26% | -$2.18M |
|
27
Target
TGT
$41.7B
| $6.02M | 1.37% |
73,136
+2,045
| +3% | +$168K |
|
28
NXP Semiconductors
NXPI
$58.6B
| $5.55M | 1.27% |
68,445
| – | – |
|
29
Johnson Controls International
JCI
$69.3B
| $5.48M | 1.25% |
140,701
-8,930
| -6% | -$348K |
|
|
XLNX
30
DELISTED
Xilinx Inc
XLNX
| $5.16M | 1.18% |
108,860
+2,335
| +2% | +$111K |
|
|
31
Perrigo
PRGO
$3.22B
| $4.85M | 1.11% |
37,916
+6,214
| +20% | +$795K |
|
32
Cisco
CSCO
$267B
| $4.66M | 1.06% |
163,750
-3,900
| -2% | -$111K |
|
33
Helmerich & Payne
HP
$2.03B
| $4.05M | 0.92% |
68,849
+1,090
| +2% | +$64.1K |
|
34
GE Aerospace
GE
$292B
| $3.9M | 0.89% |
122,597
-7,125
| -5% | -$226K |
|
|
EMC
35
DELISTED
EMC CORPORATION
EMC
| $3.81M | 0.87% |
142,896
-94,509
| -40% | -$2.52M |
|
36
Chevron
CVX
$318B
| $3.31M | 0.76% |
34,682
-3,261
| -9% | -$311K |
|
37
Xylem
XYL
$34.1B
| $2.93M | 0.67% |
71,578
+4,830
| +7% | +$198K |
|
38
General Mills
GIS
$26.2B
| $2.89M | 0.66% |
45,536
-2,619
| -5% | -$166K |
|
39
Illumina
ILMN
$15.3B
| $2.78M | 0.63% |
17,149
+100
| +0.6% | +$16.2K |
|
40
Pembina Pipeline
PBA
$21.7B
| $2.7M | 0.62% |
99,875
-6,045
| -6% | -$163K |
|
|
41
Gilead Sciences
GILD
$140B
| $2.4M | 0.55% |
26,074
+17,353
| +199% | +$1.59M |
|
42
Novo Nordisk
NVO
$251B
| $2.24M | 0.51% |
41,270
-695
| -2% | -$37.7K |
|
43
Qualcomm
QCOM
$170B
| $2.23M | 0.51% |
43,584
+12,622
| +41% | +$646K |
|
44
J.M. Smucker
SJM
$11.8B
| $2.18M | 0.5% |
16,812
-235
| -1% | -$30.5K |
|
45
Colgate-Palmolive
CL
$67.3B
| $2.08M | 0.47% |
29,430
-115
| -0.4% | -$8.13K |
|
46
State Street
STT
$32B
| $2.08M | 0.47% |
35,454
-2,545
| -7% | -$149K |
|
47
Merck
MRK
$212B
| $1.97M | 0.45% |
37,107
-4,835
| -12% | -$256K |
|
48
AbbVie
ABBV
$375B
| $1.83M | 0.42% |
32,040
-4,385
| -12% | -$251K |
|
|
49
Danaher
DHR
$145B
| $1.42M | 0.32% |
14,940
+12,440
| +498% | +$1.18M |
|
50
Bristol-Myers Squibb
BMY
$97B
| $1.39M | 0.32% |
21,750
-500
| -2% | -$32K |
|